Persistent gestational trophoblastic disease: results of MEA (methotrexate, etoposide and dactinomycin) as first-line chemotherapy in high risk disease and EA (etoposide and dactinomycin) as second-line therapy for low risk disease

Persistent gestational trophoblastic disease is potentially fatal, but the majority of patients are cured with chemotherapy. Any developments in treatment are therefore being directed towards maintaining efficacy and reducing toxicity. We evaluated efficacy and toxicity of methotrexate, etoposide an...

Descripción completa

Detalles Bibliográficos
Autores principales: Dobson, L S, Lorigan, P C, Coleman, R E, Hancock, B W
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2000
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363400/
https://www.ncbi.nlm.nih.gov/pubmed/10789722
http://dx.doi.org/10.1054/bjoc.2000.1176

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363400/
https://www.ncbi.nlm.nih.gov/pubmed/10789722
http://dx.doi.org/10.1054/bjoc.2000.1176

Ejemplares similares